Shanghai, China – Evonik’s integrated manufacturing base for isophorone and isophorone diamine plants in Shanghai with a 50kT/year capacity started operation in May 2014. The project, located in Shanghai Chemical Industry Park, commenced in 2012 and has cost more than €100mn ($136m).
According to Evonik’s announcement, the growth rate of isophorone and relevant products has exceeded that of the world GDP, and Asia has outperformed the average. The new plants will be supplying the Asia market in sectors including coatings, paint, construction, adhesives and compounds.
“Currently we have similar business sizes in Europe, North America and Asia, and the integrated facilities will bring us attractive new growth opportunities,” said Evonik executive board member and COO Patrik Wohlhauser in the announcement.
In 2013 Evonik had €2bn operating profit on €12.7bn revenue; the Greater China area contributed €1bn revenue with 3,200 employees in the region.
XE Currency Conversion: 2 June, 2014